These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7636524)

  • 21. Cell kinetics: from tritiated thymidine to flow cytometry.
    Terry NH; White RA; Meistrich ML
    BJR Suppl; 1992; 24():153-7. PubMed ID: 1290691
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of cytometry in the studies of the proliferative activity of neoplastic cells.
    Krygier-Stojalowska A; Kuchnio M; Homenda W; Halajko A
    Acta Histochem Suppl; 1990; 39():67-79. PubMed ID: 2080295
    [No Abstract]   [Full Text] [Related]  

  • 23. [Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the analysis of tumor cell kinetics by flow cytometry].
    Kanno M; Takeda Y; Nakamura S
    Nihon Rinsho; 1992 Oct; 50(10):2333-7. PubMed ID: 1280304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Past and present concepts in flow cytometry: a European perspective.
    Valet G
    J Biol Regul Homeost Agents; 2003; 17(3):213-22. PubMed ID: 14524606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between radiosensitivity and cell kinetic effects after low- and high-dose-rate irradiation in five human tumors in nude mice.
    van Oostrum IE; Erkens-Schulze S; Petterson M; Wils IS; Rutgers DH
    Radiat Res; 1990 Jun; 122(3):252-61. PubMed ID: 2356278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
    Albers P; Ulbright TM; Albers J; Miller GA; Orazi A; Crabtree WN; Baniel J; Reister T; Sidner RA; Foster RS; Donohue JP
    J Urol; 1996 Feb; 155(2):579-86. PubMed ID: 8558664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality control in image cytometry: DNA ploidy.
    Bacus JW; Bacus JV
    J Cell Biochem Suppl; 1994; 19():153-64. PubMed ID: 7823587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploiting tumor shrinkage through temporal optimization of radiotherapy.
    Unkelbach J; Craft D; Hong T; Papp D; Ramakrishnan J; Salari E; Wolfgang J; Bortfeld T
    Phys Med Biol; 2014 Jun; 59(12):3059-79. PubMed ID: 24839901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Flow cytometric analysis of Ki-67 reactive antigen].
    Murakami T; Sasaki K; Takahashi M
    Nihon Rinsho; 1992 Oct; 50(10):2355-9. PubMed ID: 1280305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cancer cells and apoptosis].
    Suzuki N; Sakai K; Matsumoto Y
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):997-1005. PubMed ID: 8512343
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor cell kinetics using two labels and flow cytometry.
    Ritter MA; Fowler JF; Kim YJ; Gilchrist KW; Morrissey LW; Kinsella TJ
    Cytometry; 1994 May; 16(1):49-58. PubMed ID: 8033734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Optimization of the timing of dose distribution in radiation therapy].
    Kozlov AP; Afanas'ev BP; Antonevich OV; Akimov AA
    Med Radiol (Mosk); 1985 Jun; 30(6):49-52. PubMed ID: 4021753
    [No Abstract]   [Full Text] [Related]  

  • 34. The radiobiological and physical basis for radiotherapy with protons and heavier ions.
    Kraft G
    Strahlenther Onkol; 1990 Jan; 166(1):10-3. PubMed ID: 2154042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.
    Jung KM; Jang WH; Lee YK; Yum YN; Sohn S; Kim BH; Chung JH; Park YH; Lim KM
    Toxicol Lett; 2012 Mar; 209(3):255-63. PubMed ID: 22245253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
    Røe K; Aleksandersen TB; Kristian A; Nilsen LB; Seierstad T; Qu H; Ree AH; Olsen DR; Malinen E
    Acta Oncol; 2010 Oct; 49(7):914-21. PubMed ID: 20831478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence drift detection as a novel QC procedure for DNA cell-cycle analysis.
    Seamer LC; Altobelli KK
    Cytometry; 1995 Mar; 22(1):60-4. PubMed ID: 7587735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
    Webster L; Hodgkiss RJ; Wilson GD
    Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.